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ABSTRACT 
Background and Objectives: We investigated the effects of different concentrations of serum, 5-azacytidine, and 
culture time on the cardiomyogenic differentiation of P19 embryonal carcinoma stem cells in the course of devel-
oping an efficient protocol for generating the cardiomyogenic lineage. Materials and Methods: P19 cells were 
plated at a density of 1×10
6 cells on 10-cm bacterial dishes for 96 hours in the presence of 1% dimethyl sul-
foxide to form embryoid bodies. The embryoid bodies were cultured in medium with 2% or 10% fetal bovine 
serum for an additional 10 or 15 consecutive days in the presence of 0, 1, or 3 μ M 5-azacytidine. Results: Quan-
titative real-time polymerase chain reaction (PCR) analysis showed that the messenger ribonucleic acid (mRNA) 
expression of cardiac muscle-specific genes, such as GATA4, α-actin, α-myosin heavy chain, and cardiac tropo-
nin T, were significantly higher in the 15-day culture groups than in the 10-day culture groups. Furthermore, the 
cardiac muscle-specific genes were expressed more in the high-serum groups compared to the low-serum groups 
regardless of the culture time. Cardiomyogenic differentiation of the P19 cells was most effective in 1 μ M 5-aza-
cytidine regardless of the serum concentrations. In addition, the stimulation effects of 5-azacytidine on cardio-
myogenic differentiation were more significant under low-serum culture conditions compared to high-serum culture 
conditions. Cardiomyogenic differentiation of P19 cells was further confirmed by immunostaining with cardiac mu-
scle-specific antibodies. Conclusion: Taken together, these results demonstrated that cardiomyogenic differentiation 
of P19 cells was enhanced by a combination of different experimental factors. (Korean Circ J 2009;39:198-204) 
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Introduction 
 
Ischemic heart disease is the leading cause of death 
worldwide. Recently, cell therapy for the treatment of 
heart failure has received considerable attention after 
new discoveries on the potential of adult stem cells 
showed an ability to differentiate into functional car-
diomyocytes.
1-4) However, the plasticity of bone marrow 
cells has been challenged by alternative mechanisms, such 
as cell fusion and paracrine action, but not transdiffer-
entiation.
5)6) Questions and controversies with regard 
to the mechanisms of myocardial regeneration still exist. 
In this context, studies are needed to elucidate the mo-
lecular mechanisms underlying cardiomyogenic differ-
entiation of adult stem cells, as well as embryonic stem 
cells, in order to make progress toward the clinical ap-
plication of cell therapy in patients with cardiovascular 
diseases.  
The P19 embryonal carcinoma stem cell line has been 
widely used as a model system for the study of molec-
ular mechanisms underlying cardiomyogenic differen-
tiation.
7-9) These cells can be maintained in an undif-
ferentiated state in a monolayer without a feeder-cell 
layer. Such conditions allow for easy introduction of 
ectopic genes and the performance of experiments re-
quiring a large quantity of cells.
9)10) Cardiomyogenic dif-
ferentiation of P19 cells has generally been induced by 
embryoid body (EB) formation in the presence of 0.5-
1% dimethyl sulfoxide (DMSO) in bacterial dishes.
7) 
We previously showed that 5-azacytidine could induce 
cardiac differentiation of P19 cells under confluent mo-
nolayer culture conditions without prior EB formation 
and DMSO exposure.
9) To date, however, the differenti-
ation efficacy of P19 cells to develop into the cardio-
myogenic lineage remains low. Therefore, in this study 
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we examined the effects of different culture conditions, 
including different concentrations of serum, 5-azacy-
tidine, and culture time, on cardiomyogenic differenti-
ation of P19 cells. The goal was to develop an efficient 
protocol for directing cardiomyogenic differentiation 
of P19 cells.   
 
Materials and Methods 
 
Culture and cardiac differentiation of P19 cells 
The P19 cells were obtained from the American Type 
Culture Collection (ATCC, Rockville, MD, USA). The 
cells were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM; Gibco-BRL, Grand Island, NY, USA) 
supplemented with 10% fetal bovine serum (FBS, Gi-
bco-BRL), 100 units of penicillin/mL, and 100 μg of 
streptomycin/mL. To induce cardiac differentiation, EB 
formation was induced by plating P19 cells on 10-cm 
bacterial dishes with 1×10
6 cells in 10 mL of DMEM 
supplemented with 1% DMSO (Sigma, St. Louis, MO, 
USA), 10% FBS, 100 units of penicillin/mL, and 100 
μg of streptomycin/mL for 96 hours. The formed EBs 
were transferred to 24-well plates, and cultured in DM-
EM with 2% or 10% FBS for an additional 10 or 15 
consecutive days in the presence of 0, 1, and 3 μ M of 
5-azacytidine (Sigma). The morphologic changes of the 
P19 cells were examined under an inverted microscope 
(Nikon, Tokyo, Japan) equipped with phase-contrast 
objectives and a digital camera.   
 
Real-time polymerase chain reaction 
Total ribonucleic acid (RNA) was extracted from 
P19 cells with Trizol reagent (Invitrogen, Carlsbad, CA, 
USA). Then, 0.5 μg of the total RNAs was treated 
with DNase (Promega, Madison, WI, USA) to remove 
the contaminated genomic deoxyribonucleic acid (DNA). 
The first-strand complementary DNA (cDNA) was syn-
thesized from 0.5 μg of DNase-treated total RNA us-
ing 0.5 μg random hexamers, and 200 U Moloney mu-
rine leukemia virus reverse transcriptase (Invitrogen) at 
37℃ for 60 minutes in a volume of 20 μL. The first 
strand cDNA (1 μL) was used for polymerase chain 
reaction (PCR) amplification in a 25 μL reaction mix-
ture. Real-time PCR was performed using an iQ
TM Cy-
cler (Bio-Rad, Hercules, CA, USA); each reaction con-
tained 25 μL of the iQ
TM SYBER Green Supermix 
(Bio-Rad), 3 μL of forward primer (5 μM), 3 μL of 
reverse primer (5 μ M), 5 μ L of a 1 : 20 dilution of a 
cDNA, and 14 μL of H2O. The PCR conditions in-
cluded a denaturation step (95℃ for 3  minutes), am-
plification and quantification repeated 45 times (94℃ 
for 15 seconds, 60℃  for 30 seconds, and 72℃ for  30 
seconds), and melting curve analysis (55-95℃ with a 
heating rate of 0.05℃/second). The primers used for 
real-time PCR were as follows: GATA4 (CCTGCGGC 
CTCTACATGA, AGGGTCTCACCAGCAGGA, 136 
bp); alpha-cardiac muscle actin (α -actin; GGAGAAG 
AGCTATGAACTTCCTGA, GCCAGCAGATTCCA 
TACCA, 112 bp); alpha-cardiac myosin heavy chain 
(α-MHC; GGATTCTCTGAAAAGTTAACCAGAGT, 
GGCGTTCCTTCTCTGACTTTC, 108 bp); cardiac 
muscle troponin T (cTnT; GGCTCACTTCGAGAAC 
AGGA, TCATTGCGAATACGCTGCT, 108 bp); and 
GAPDH (TTCACCACCATGGAGAAGGC, GGCAT 
GGACTGTGGTCATGA, 237 bp). For the selection 
of primers for real-time PCR, we designed intron span-
ning primers following the Roche Universal Probe Li-
brary method (www.roche-applied-science.com) to avoid 
genomic DNA amplification. We then selected primers 
that generated a single band of PCR product with the 
expected size by performing a standard reverse trans-
criptase-PCR (RT-PCR) (data not shown). The final 
primers were selected based on the linearity of the th-
reshold cycle (Ct) values obtained in the serial dilutions 
of the template, with the negative controls containing 
no template.   
The measurement of gene expression was assayed in 
triplicate. The relative gene expression levels were quan-
tified based on the Ct, and normalized to the reference 
gene GAPDH. 
 
Immunocytochemistry 
For the immunostaining procedure, P19 cells were 
plated at a density of 1×10
6 cells on 10-cm bacterial 
dishes for 96 hours in the presence of 1% DMSO. The 
formed EBs were transferred onto 0.1% gelatin-coated 
coverslips in 12-well dishes, and cultured in DMEM 
with 10% FBS for an additional 10 days in the pre-
sence of 1 μM of 5-azacytidine. The formed EBs were 
then fixed during 20 minutes of incubation in PBS con-
taining 4% paraformaldehyde, and then rinsed in PBS 
containing 0.1% Tween 20 (PBT) three times. The fixed 
cells were permeabilized for 30 minutes in PBS con-
taining 0.5% Triton X-100, and then blocked with 10% 
normal goat serum in PBT for 1 hour. The cells were 
then incubated with sarcomeric α -actinin, cardiac myo-
sin heavy chain, cardiac myosin light chain, and cTnT 
(all from Sigma) at 4℃ overnight in 2% normal goat 
serum in PBT. After washing in PBT, the cells were then 
stained with secondary Alexa Fluor488-conjugated anti-
rat IgG (Molecular Probes, Eugene, OR, USA) for 30 
minutes at room temperature, and washed three times 
in PBT. For the control experiments, the cells were st-
ained with secondary antibodies only. The nuclei were 
stained with 4’6’-diamidino-2-phenylindole  (DAPI), 
and the cells were mounted with fluorescent mounting 
medium (Dako, Carpinteria, CA, USA).  
The fluorescence images were obtained using the TE-
FM Epi-Fluorescence system attached to an Olympus 
inverted microscope (Olympus, Tokyo, Japan).  
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Statistical analysis 
The statistical analyses were performed using a t-test 
or the Student-Newman-Keuls’ multiple comparison 
test. Statistical significance was set a priori at a p<0.05. 
All statistical values are expressed as the mean±stand-
ard deviation (SD). All statistical analyses were performed 
using SigmaStat3.1 software (SPSS Inc., Chicago, IL, 
USA). 
 
Results 
 
Effects of culture time on cardiomyogenic differen-
tiation of the P19 cells 
We examined the effects of culture time on cardio-
myogenic differentiation of the P19 cells by SYBR 
Green-based quantitative real-time PCR assays with 
primers for GATA4, α-actin, α-MHC, and cTnT as 
cardiac-specific markers. The P19 cells were maintained 
in a monolayer of DMEM+10% FBS before induction 
of cardiac differentiation (Fig. 1A). To induce cardiac 
differentiation, they were cultured in a suspension in 
bacterial dishes for 96 hours in DMEM+10% FBS 
containing 1% DMSO to form EBs (Fig. 1B); the EBs 
were further cultured for 10 or 15 consecutive days in 
DMEM+10% FBS. Expression of GATA4, α-actin, 
α-MHC, and cTnT mRNA cardiac-specific markers 
was -1.97, -4.93, -33.54, and -15.92-fold higher, res-
pectively, in 20-day cultures of P19 cells than 15-day 
cultures of P19 cells (Fig. 2). This result shows that car-
diomyogenic differentiation of P19 cells increases as the 
culture time is extended. 
 
Effects of serum concentration on cardiomyoge-
nic differentiation of the P19 cells 
We also analyzed the effect of serum concentrations 
on cardiomyogenic differentiation of the P19 cells by 
quantitative real-time PCR assay. The P19 cells were 
cultured in suspension in bacterial dishes for 96 hours 
F
o
l
d
 
i
n
c
r
e
a
s
e
 
10
8
6
4
2
0
1.00 
1.97 
2%  FBS        10%  FBS 
F
o
l
d
 
i
n
c
r
e
a
s
e
 
10
8
6
4
2
0
2%  FBS        10%  FBS 
F
o
l
d
 
i
n
c
r
e
a
s
e
 
50
40
30
20
10
0
1.00 
2%  FBS        10%  FBS 
F
o
l
d
 
i
n
c
r
e
a
s
e
 
20
15
10
5
0
2% FBS        10%  FBS 
1.00 
4.93 
15.92 
*p=0.005 
 
1.00 
33.54 
*p<0.001 
 
*p=0.003 
 
GATA 4  α-actin  α-MHC  cTnT 
Fig. 2. Effects of culture period on cardiomyogenic differentiation of P19 cells. To form EBs, P19 cells were plated at a density of 1×10
6
cells on 10-cm bacterial dishes for 96 hours in the presence of 1% DMSO. The formed EBs were transferred onto 24-well plates, and
cultured in DMEM+10% FBS for an additional 10 or 15 consecutive days. Real-time PCR was carried out using total RNAs isolated from
the P19 cells on days 10 and 15 of differentiation with primers for GATA4, α -actin, α -MHC, and cTnT. The relative gene expression le-
vels were quantified based on the threshold cycle, and normalized to the reference gene GAPDH. α -actin: alpha-cardiac muscle actin,
α -MHC: alpha-cardiac myosin heavy chain, cTnT: cardiac muscle troponin T, DMEM: Dulbecco’s modified Eagle’s medium, DMSO:
dimethyl sulfoxide, EB: embryoid body, FBS: fetal bovine serum, RNA: ribonucleic acid. 
Fig. 1. DMSO-induced EB formation from P19 cells. P19 cells were plated at a density of 1×10
6 cells on 10-cm bacterial dishes for 96 
hours in the presence of 1% DMSO to form EBs that contained cells differentiated into cardiomyogenic lineages. A: undifferentiated P19 
cells were maintained in a monolayer. B: the formed EBs were examined under an inverted microscope at 96 hours for cardiac dif-
ferentiation. Scale bars=100 μm. DMSO: dimethyl sulfoxide, EB: embryoid body. 
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in DMEM+10% FBS containing 1% DMSO to form 
EBs; the EBs were further cultured for 10 or 15 conse-
cutive days in DMEM containing 2% or 10% FBS. The 
expression of GATA4, α-actin, α-MHC, and cTnT 
mRNA in the EBs cultured in DMEM containing 10% 
FBS were -7.15, -1.62, -8.35, and -6.75-fold higher, re-
spectively, than the EBs cultured in DMEM containing 
2% FBS for 10 consecutive days after EB formation 
(Fig. 3A). Furthermore, the expression of GATA4, α -
actin, α-MHC, and cTnT mRNA in the EBs cultured 
in DMEM containing 10% FBS were also -1.84, -3.14, 
-3.42, and -2.41-fold higher, respectively, than the EBs 
cultured in DMEM containing 2% FBS for 15 con-
secutive days after EB formation (Fig. 3B). This result 
demonstrates that cardiomyogenic differentiation of 
the P19 cells was enhanced under high-serum culture 
conditions (10% FBS) compared to low-serum culture 
conditions (2% FBS), regardless of the culture time. 
 
Effects of 5-azacytidine on cardiomyogenic differ-
entiation of the P19 cells under different serum 
concentrations 
Several studies have reported that 5-azacytidine, a 
DNA hypomethylating agent, stimulates the cardiac dif-
ferentiation of stem cells isolated from various tissues, 
such as mesenchymal stem cells,
11) human embryonic 
cells,
12) cardiac stem cells,
13) and P19 cells.
9) Based on pre-
vious reports, we investigated the effects of 5-azacytidine 
on cardiomyogenic differentiation of the P19 cells by qu-
antitative real-time PCR assay. The P19 cells were cultured 
in suspension in bacterial dishes for 96 hours in DM-
EM+10% FBS containing 1% DMSO to form EBs; 
the EBs were further cultured for 10 consecutive days 
in DMEM containing 2% (Fig. 4A) or 10% FBS (Fig. 
4B). The expression of cardiac-specific markers, such 
as GATA4, α-MHC, and cTnT mRNA was highest in 
the cells treated with 1 μ M 5-azacytidine, regardless of 
the serum concentrations (Fig. 4). In addition, the cells 
treated with 3 μM 5-azacytidine showed a statistically 
significant increase in the expression of cardiac-specific 
markers compared to the control cells (Fig. 4). This re-
sult demonstrates that cardiomyogenic differentiation 
of the P19 cells was the most effective with 1 μ M of 5-
azacytidine, regardless of the serum concentrations. In 
addition, stimulation by 5-azacytidine for cardiomyo-
genic differentiation was more distinct under low-se-
rum culture conditions (2% FBS) compared to high-
serum culture conditions (10% FBS).  
To further confirm the cardiomyogenic differentia-
tion of the P19 cells at the protein level, we performed 
immunostaining with antibodies against cardiac-spe-
cific markers, including sarcomeric α -actinin, cardiac 
Fig. 3. Effects of serum concentration on cardiomyogenic differentiation of P19 cells. To form EBs, the P19 cells were plated at a density
of 1×10
6 cells on 10-cm bacterial dishes for 96 hours in the presence of 1% DMSO. The formed EBs were transferred into 24-well 
plates, and cultured in DMEM with 2% or 10% FBS for an additional 10 or 15 consecutive days. Real-time PCR was carried out using 
total RNAs isolated from the P19 cells cultured in DMEM with 2% or 10% FBS on day 10 (A) and day 15 (B) of differentiation with pri-
mers for GATA4, α -actin, α -MHC, and cTnT. The relative gene expression levels were quantified based on the threshold cycle (Ct), and 
normalized to the reference gene GAPDH. α -actin: alpha-cardiac muscle actin, α -MHC: alpha-cardiac myosin heavy chain, cTnT: car-
diac muscle troponin T, DMEM: Dulbecco’s modified Eagle’s medium, DMSO: dimethyl sulfoxide, EB: embryoid body, FBS: fetal bovine 
serum, PCR: polymerase chain reaction, RNA: ribonucleic acid. 
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myosin heavy chain, cardiac myosin light chain, and 
cTnT after induction of cardiomyogenic differentiation 
of the P19 cells. The P19 cells were plated at a density of 
1×10
6 cells on 10-cm bacterial dishes for 96 hours in 
the presence of 1% DMSO. The formed EBs were trans-
ferred onto 0.1% gelatin-coated coverslips in 12-well 
dishes, and cultured in DMEM with 10% FBS for an 
additional 10 consecutive days in the presence of 1 μM 
5-azacytidine. A number of cells showing specific stain-
ing patterns for cardiac-specific markers were observed 
in the cardiomyocytes differentiated from the P19 cells 
(Fig. 5). 
 
Discussion 
 
Cardiomyocyte differentiation of stem cells in vitro is 
known to be affected by various environmental factors, 
such as the incubation period, medium composition, 
serum components, growth factors, and chemicals. Th-
erefore, in this study, we investigated the effects of 
different concentrations of serum and 5-azacytidine, 
and culture time on the cardiomyogenic differentia-
tion of P19 cells. We showed that cardiomyogenic dif-
ferentiation of the P19 cells was enhanced in parallel 
with the length of the culture period. This result was 
in agreement with our previous findings that showed 
that the expression of cardiac-specific markers, such as 
GATA4, Nkx2.5, and cTnT after treatment with 1 μ M 
5-azacytidine in a P19 cell monolayer culture was up-
regulated in a time-dependent manner.
9) 
In the present study, we compared the effects of se-
rum concentrations on cardiac differentiation of the 
P19 cells. We showed that cardiomyogenic differen-
tiation of the P19 cells was enhanced by high FBS (10%)-
containing medium compared to low FBS (2%)-con-
taining medium, regardless of the culture time period. 
Investigation of the stimulatory or inhibitory effects of 
FBS concentration on the cardiac differentiation of stem 
cells has been previously reported. Medium containing 
20% FBS has been shown to promote more rapid down-
regulation of the pluripotency marker, Oct 4, and in-
creased expression of endodermal and mesodermal genes 
at the time of EB formation of H1 human embryonic 
stem cells (ESCs), compared to medium with 20% 
KnockOut serum replacement, in which spontaneous-
ly-beating cardiomyocytes were only observed in the 
FBS-treated group.
14) Moreover, bone morphogenetic 
protein 4 (BMP-4) was not shown to induce cardiomyo-
cyte differentiation in mouse ESCs with serum-free 
models; at least a small amount of FBS in the hanging 
Fig. 4. Effects of 5-azacytidine on cardiomyogenic differentiation of P19 cells under different serum concentrations. To form EBs, P19
cells were plated at a density of 1×10
6 cells on 10-cm bacterial dishes for 96 hours in the presence of 1% DMSO. The formed EBs were 
transferred into 24-well plates, and cultured in DMEM with 2% or 10% FBS for an additional 10 consecutive days in the presence of 0, 1,
and 3 μM 5-azacytidine. Real-time PCR was carried out using total RNAs isolated from the P19 cells cultured in DMEM with 2% FBS
(A) or 10% FBS (B) in the presence of 0, 1 and 3 μM of 5-azacytidine on day 10 of differentiation with primers for GATA4, α-MHC, and 
cTnT. The relative gene expression levels were quantified based on the threshold cycle (Ct), and normalized to the reference gene 
GAPDH. α-actin: alpha-cardiac muscle actin, α-MHC: alpha-cardiac myosin heavy chain, cTnT: cardiac muscle troponin T, DMEM:
Dulbecco’s modified Eagle’s medium, DMSO: dimethyl sulfoxide, EB: embryoid body, FBS: fetal bovine serum, PCR: polymerase chain 
reaction, RNA: ribonucleic acid. 
*p=0.018 
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drop stage is necessary. These findings suggest that se-
rum factors are not critical after the initial activation, 
but do enhance the differentiation of cardiomyocytes.
15) 
By contrast, the number of beating areas in the co-cul-
ture model with END-2 cells was increased 24-fold in 
the absence of fetal calf serum (FCS) compared to the 
cells in the presence of 20% FCS.
16) These results sug-
gest that pro- and anti-cardiogenic factors may be pre-
sent in the serum. The stimulatory or inhibitory effects 
of the serum concentration on cardiac differentiation 
may be different in various stem cell lines and culture 
conditions.  
Cardiomyogenic differentiation of P19 cells has gen-
erally been induced with the combination of EB for-
mation and DMSO in bacterial dishes.
7) However, we 
previously reported that 5-azacytidine induced cardio-
myogenic differentiation of P19 cells in confluent mo-
nolayer cultures without prior EB formation and DM-
SO exposure via, in part, activation of BMP signaling 
molecules.
9) In this context, we investigated whether 5-
azacytidine could enhance cardiomyogenic differenti-
ation of P19 cells at the stage of preformed EB in the 
presence of DMSO in bacterial dishes. Our results 
showed that 1 μM 5-azacytidine-treated cells had the 
most enhanced cardiomyogenic differentiation of P19 
cells, both under low-serum culture conditions (2% FBS) 
and high-serum culture conditions (10% FBS), com-
pared to the 5-azacytidine non-treated control group 
and the 3 μ M 5-azacytidine-treated group. This ob-
servation is consistent with the findings of our previous 
report
9) that P19 cells differentiated into the cardio-
myogenic cell lineage in response to 1 μM 5-azacytidine 
in a confluent monolayer culture. Various concentra-
tions of 5-azacytidine with different treatment periods 
have been used to induce cardiomyogenic differentia-
tion of mesenchymal stem cells derived from different 
species. Murine bone marrow stromal cells were treated 
with 3 μ M 5-azacytidine for 24 hours, and sponta-
neously-beating cells were observed after 2 weeks.
11) Me-
senchymal stem cells isolated from adult human bone 
marrow were reported to differentiate to a cardiomyo-
genic lineage in vitro after treatment with 10 μM 5-
azacytidine for 24 hours.
17) Adult mesenchymal stem 
cells isolated from the fatty tissue of New Zealand White 
Sarcomeric α-actinin   Myosin Heavy Chain  Myosin Light Chain  Cardiac Troponin T 
DAPI  
Merge 
DAPI   DAPI  DAPI  
Merge  Merge Merge 
Fig. 5. Immunostaining of P19 cell-derived cardiomyocytes after 5-azacytidine treatment. To form EBs, the P19 cells were plated at a 
density of 1×10
6 cells on 10-cm bacterial dishes for 96 hours in the presence of 1% DMSO. The formed EBs were transferred onto 0.1%
gelatin-coated coverslips in 12-well dishes, and cultured in DMEM with 10% FBS for an additional 10 consecutive days in the presence 
of 1 μM 5-azacytidine. The cells were stained with sarcomeric α-actinin, cardiac myosin heavy chain, cardiac myosin light chain, and 
cardiac troponin T as indicated. DAPI was used for staining the nuclei. Scale bars, 100 μm. DAPI: 4’6’-diamidino-2-phenylindole, 
DMEM: Dulbecco’s modified Eagle’s medium, DMSO: dimethyl sulfoxide, EB: embryoid body, FBS: fetal bovine serum.  
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rabbits were treated with 1, 3, 6, 9, and 12 μ M 5-azacy-
tidine and incubated for 12, 24, 48, and 72 hours.
18) 
Taken together, our results and previous reports suggest 
that the optimal concentration and treatment time 
with 5-azacytidine for the induction of cardiomyogenic 
differentiation appears to depend on both the efficacy 
of cardiac differentiation and the cytotoxicity of the 
stem cells.   
In conclusion, the results of this study demonstrated 
that cardiomyogenic differentiation of P19 cells could 
be enhanced by a combination of different experimen-
tal factors, including the concentration of the serum 
and 5-azacytidine, as well as the culture time. 
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